206
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Improving blood pressure control rates by optimizing combination antihypertensive therapy

, PharmD BCPS
Pages 2011-2026 | Published online: 30 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ting-Yu Ho, Paul A. Fishman & Zelda B. Zabinsky. (2019) Using a game-theoretic approach to design optimal health insurance for chronic disease. IISE Transactions on Healthcare Systems Engineering 9:1, pages 26-40.
Read now

Articles from other publishers (8)

Benjamin J. Epstein, Niren K. Shah & Nancy L. Borja-Hart. (2013) Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease 7:5, pages 246-259.
Crossref
Joel M Neutel. (2013) Treatment algorithms for hypertension: a practical approach. Clinical Practice 10:3, pages 333-344.
Crossref
Danielle Pierini & Katherine Vogel Anderson. (2013) Azilsartan Medoxomil/Chlorthalidone: A New Fixed-Dose Combination Antihypertensive. Annals of Pharmacotherapy 47:5, pages 694-703.
Crossref
Markus Tölle & Markus van der Giet. (2013) Renale Denervation als Therapieoption. CardioVasc 13:1, pages 38-44.
Crossref
C. Venkata S. Ram, Krishnan Ramaswamy, Chunlin Qian, Joe Biskupiak, Amy Ryan, Ruth Quah & Patricia A. Russo. (2011) Blood Pressure Outcomes in Patients Receiving Angiotensin II Receptor Blockers in Primary Care: A Comparative Effectiveness Analysis From Electronic Medical Record Data. The Journal of Clinical Hypertension 13:11, pages 801-812.
Crossref
. (2011) Current World Literature. Current Opinion in Nephrology & Hypertension 20:5, pages 561-571.
Crossref
Martin J. Brodie, Athanasios Covanis, Antonio Gil-Nagel, Holger Lerche, Emilio Perucca, Graeme J. Sills & H. Steve White. (2011) Antiepileptic drug therapy: Does mechanism of action matter?. Epilepsy & Behavior 21:4, pages 331-341.
Crossref
George W Booz. (2010) Novel Drugs Targeting Hypertension Revisited. Journal of Cardiovascular Pharmacology 56:3, pages 213-214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.